92 reports of this reaction
2.6% of all FELBAMATE reports
#6 most reported adverse reaction
CONDITION AGGRAVATED is the #6 most commonly reported adverse reaction for FELBAMATE, manufactured by Viatris Specialty LLC. There are 92 FDA adverse event reports linking FELBAMATE to CONDITION AGGRAVATED. This represents approximately 2.6% of all 3,510 adverse event reports for this drug.
Patients taking FELBAMATE who experience condition aggravated should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CONDITION AGGRAVATED is a less commonly reported adverse event for FELBAMATE, but still significant enough to appear in the safety profile.
In addition to condition aggravated, the following adverse reactions have been reported for FELBAMATE:
The following drugs have also been linked to condition aggravated in FDA adverse event reports:
CONDITION AGGRAVATED has been reported as an adverse event in 92 FDA reports for FELBAMATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
CONDITION AGGRAVATED accounts for approximately 2.6% of all adverse event reports for FELBAMATE, making it a notable side effect.
If you experience condition aggravated while taking FELBAMATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.